Theranostics Market By Therapeutic Area (Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, and Cervical Cancer), Cardiovascular Diseases, Neurological Disorders, and Immunological Disorders), By Technology (Polymerase Chain Reaction, Immunohistochemistry, and In Situ Hybridization, Sequencing), By End User (Hospital and Diagnostic Laboratories), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030

Theranostics market segmentation by geography includes Latin America, the Middle East, Africa, North America, Europe, and Asia Pacific. In comparison to other regions, North America's market is anticipated to hold a significant portion of the revenue share. Leading manufacturers in the area, partnerships, active research and development, and the rising use of companion diagnostics in the member states are all responsible for this. Additionally, the Asia Pacific market is predicted to have the second-highest revenue share in the global industry, behind the European market.